Li-Fraumeni syndrome (LFS) is a high-risk hereditary cancer predisposition syndrome affecting 1 in 5000 individuals. Current ...

With one plasma p-tau217 test being approved just last May by the U.S. Food and Drug Administration and others likely to follow suit this year, this marker is poised to change the way clinicians ...

Frontiers in Biotechnology and Bioengineering is launching a special issue titled – "False Positives and Negative Results in Protein Sciences" within the ...

2) The Oral Glucose Tolerance Test (OGTT) evaluates blood sugar levels two hours post-consumption of a 75 g glucose solution.

MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix”) today announces it has dosed the first patient in a Phase 3 ...